Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?

Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified? Drugs Aging. 2007; 24(11):881-90.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.